echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Jiangxi collection and harvesting program announced: up to 2 home selected the lowest price can take 50% of the volume.

    Jiangxi collection and harvesting program announced: up to 2 home selected the lowest price can take 50% of the volume.

    • Last Update: 2020-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On July 23, Jiangxi Province issued the "Jiangxi Province Drug Tape Procurement Document (Draft for Comments)", published the 7 varieties of agreed procurement volume, procurement cycle, declaration eligibility and other detailed details, and publicly solicited comments.
    including a total of 7 varieties including 5 PPI drugs included in this collection.
    the agreed purchase volume of each variety shall be determined according to the following rules: 1 enterprise is selected, take 50% of the annual purchase volume as the agreed purchase volume, and 2 at home, take 75% of the annual purchase volume as the agreed purchase volume, of which 50% as the agreed purchase volume of the lowest-priced winning enterprise, 25% as the agreed purchase volume of the highest-ranked enterprise.
    procurement cycle: 1 in the selection of enterprises, the procurement period is 1 year, and 2 selected in 2 enterprises, the procurement cycle is 2 years.
    purchase and sale agreement signed every year during the purchase cycle.
    if the purchase period in advance of the completion of the current year's agreed purchase volume, more than part of the selected enterprises still in accordance with the selected price in a timely and sufficient amount of supply, until the purchase cycle expires.
    When the results of centralized procurement of national drugs in the procurement cycle and the results of the central drug procurement in our province cross, such as the winning enterprises are different, the results of the national drug centralized procurement are implemented;
    bid requirements: The enterprise bid variety and the auction group contain at least 1 main product regulation.
    enterprise bid varieties in 2019 production reached 2 times the quantity of this purchase (including) or more.
    the procurement cycle, medical institutions will give priority to the use of drug belt procurement of selected drugs, and ensure the completion of the agreed purchase volume.
    the remaining amount of other drugs at the appropriate price of the same variety can be purchased according to demand.
    the winning price is not disclosed through the official website within a certain time frame.
    in the process of implementation, if the selected products and the national concentrated volume procurement varieties, the implementation of the link with the relevant national policies.
    the following original text:source:Source:Supplied
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.